Sue Hammoud: Excited to Be Attending My 1st JPM Healthcare Week
Sue Hammoud, Chief Executive Officer and CEO, CSO at Y Reproductive Technologies, shared on LinkedIn:
”New year. New frontiers in reproductive medicine!
I am excited to be attending my first JPM Healthcare Week in San Francisco!
At Y-RT, we’re building the next generation of male-directed fertility medicine by engineering miniature human testes to produce sperm outside the body, giving those with no sperm or poor-quality sperm an option for genetic parenthood.
I still have a few meeting slots open and would love to connect with investors, biotech founders, and strategic partners who share our vision. DM
If you’ll be at JPM, send me a DM. I’d love to connect!
Looking forward to an exciting week in SF!”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 21, 2026, 18:17Sean Lauber: Euploid and Live Birth Rates Vary Across PGT-A Labs
-
Nov 21, 2026, 18:13Your Next Career Opportunity in Reproductive Medicine – ASRM
-
Nov 21, 2026, 18:09Can Preeclampsia Increase Your Risk of Heart Disease Later in Life? – Preeclampsia Foundation
-
Nov 21, 2026, 18:05Natalie Tam: Officially a WEST Graduate
-
Nov 21, 2026, 18:02Lucy Froese: She Was Told to Expect Six Eggs, but They Collected 18
-
Nov 21, 2026, 17:57An Effective Regulatory Framework for Surrogacy, ALRC Report – The Fertility Society of Australia and New Zealand
-
Nov 21, 2026, 17:53Irfana Koita: Should Treatment Start With IUI or IVF?
-
Nov 21, 2026, 17:50Amit Mangal: India’s Biggest IVF Chain May Be Up for Sale
-
Nov 21, 2026, 17:45Does the Vaginal Microbiome Influence the Success of IVF and Other Fertility Treatments? – ESHRE Journals
